If the patient improves with the radiation, or maintains adequate strength or performance status(sufficient strength is usually defined as able to remain up and about at least half of the waking hours), you may wish to discuss other options aside from
tarceva - such as the original plan of cisplatin
and etoposide. This is because there is a known benefit for these drugs in terms of survival when used as first option among good performance status patients.